Brind.
  1. FDA is the source of guidance for U.S. healthcare providers.
  2. FDA is the source of guidance for U.S. healthcare providers.
  3. Eli Lilly and Company operates consistent with guidance provided by the FDA.
  4. Eli Lilly and Company plans to submit a drug candidate to the FDA for review and approval.

Eli Lilly is seeking FDA approval for Zepbound and Mounjaro, tied to a $4 billion production site expansion in Kenosha, Wisconsin.

1 report, 1 independent Updated Aug 27
AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.

What happened

Some supportReported by 1 outlet

Eli Lilly is seeking FDA approval for Zepbound and Mounjaro, tied to a $4 billion production site expansion in Kenosha, Wisconsin.

Who's involved

What this event is mainly about
Eli Lilly and CompanyFDA

How it developed

Newest first. Tap a step to see who reported it.
  1. The Food and Drug Administration approved Mounjaro, a drug developed by Eli Lilly and Company.Sub-event
  2. Seeking FDA approval for Zepbound/Mounjaro products following a $4B production site expansion in Kenosha, WI.1 source

Keep exploring

Part of

Eli Lilly and Company plans to submit a drug candidate to the FDA for review and approval. All 3 developments

Within FDA is the source of guidance for U.S. healthcare providers.

The entities involved

Coverage

Newest first; wire copies grouped